Breast Health

COVID-19

Cervical Health 

Contraception

Curbside Consults

Dermatology

Drug Pipeline News

Endometriosis

Genetic Testing

Gynecologic Oncology

Gynecology

Fetal Imaging

Abnormal Obstetrical Ultrasound

Ultrasound

Women's Imaging

Breast Imaging

Women's Ultrasound

Imaging

Infertility

LARC

Legally Speaking

Life Transitions

Malpractice

Menopause

Mental Health

Noninvasive Prenatal Testing

Obstetrics

Opinion

Osteoporosis

Pediatrics

Practice Management

Pregnancy and Birth

Sexual Health

Sexually Transmitted Infections

Surgery

Technology

Urology

Uterine Fibroids

Vulvovaginal Disease

Well Woman

About

News

Media

Podcasts

Insights

Medical World News

Peer Exchange

Peers & Perspectives

Videos

Conferences

Conference Coverage

Conference Listing

Publications

Contemporary OB/GYN® Journal

Digital Supplements

CME/CE

Resources

Physician Fact Sheets

Interactive Tools

Supplements and Featured Publications

Subscribe

Editorial Board

Partnerships

Articles

A new study published in Menopause suggests that white blood cell count could serve as a key predictor of COVID-19 symptom severity, highlighting the role of inflammation in health outcomes.

Leukocyte count may predict COVID-19 severity in postmenopausal women

The Mothers and Newborns affected by Opioids - Obstetric initiative significantly increased screening, treatment access, and naloxone counseling for pregnant patients with opioid use disorder, enhancing care and reducing racial disparities.

Statewide initiative improves opioid use disorder care for pregnant patients

A recent study found insufficient evidence that oral furosemide reduces the risk of de novo postpartum hypertension, highlighting the need for close monitoring in the first 2 weeks after birth.

Study finds furosemide fails to lower postpartum hypertension risk

A study highlights chronic villitis as a specific placental injury associated with COVID-19, raising concerns about pregnancy complications such as preeclampsia and stillbirth.

COVID-19 linked to chronic villitis and placental lesions in pregnancy

Advertise

Contact Us

Job Board

Terms of Use

Privacy Policy

Do Not Sell My Personal Information

Contemporary OB/GYN

Facebook

LinkedIn

RSS Feed

Spotlight

A Psychedelic to Treat Postpartum Depression?

CMV: In the Know

RSV Roundtable

STIs

Supplement: Closing the Gap in Cervical Cancer Screening

Vaginismus: Managing a Misunderstood and Underdiagnosed Condition

Why vNOTES Make Sense for My Patients

1rem

Continuing Medical Education

Erica Stringer-Reasor, MD; Otis W. Brawley, MD; Reshma Jagsi, MD, DPhil; Roxana Guerra

Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions

16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

Pamela Ganschow, MD; Gautum Agarwal, MD; Folasade (Fola) P. May, MD, PhD, MPhil

Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care

Tina Bhutani, MD, MAS, FAAD; Rajal Patel, MD

Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach

Jessica Ailani, MD, FAHS, FAAN; Paul G. Mathew, MD, DNBPAS, FAAN, FAHS

Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine

Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings

Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine

Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents

Raj Chovatiya, MD, PhD, MSCI, FAAD; Michael Rubio, PA-C, MMSc

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

Kathleen N. Moore, MD, MS, FASCO; Susana Banerjee, MBBS, MA, FRCP, PhD; David M. O’Malley, MD; Ritu Salani, MD, MBA

Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances

Kathleen N. Moore, MD, MS, FASCO; David M. O’Malley, MD

Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer

Kathleen N. Moore, MD, MS, FASCO; Ritu Salani, MD, MBA

Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care

Kathleen N. Moore, MD, MS, FASCO; Prof Susana Banerjee, MBBS, MA, FRCP, PhD

Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

Upcoming CME Events & Activities

EVENTS

ACTIVITIES